Newmark Arranges $300M Joint Venture Between Catalyst and Heitman
Newmark Group, Inc. (Nasdaq: NMRK) has arranged a strategic joint venture between Catalyst Healthcare Real Estate and Heitman, securing $300 million to fund the development of purpose-built healthcare properties. The initial phase includes funding seven developments totaling nearly 500,000 square feet across five states, with tenants like Ochsner Health and Andrews Medicine.
The venture aims to develop medical outpatient buildings, orthopedic centers of excellence, and inpatient rehabilitation facilities. This partnership marks a significant milestone in Heitman's 20+ year history of investing in the medical office sector, leveraging the counter-cyclical qualities of this needs-based asset class.
Newmark Group, Inc. (Nasdaq: NMRK) ha organizzato una joint venture strategica tra Catalyst Healthcare Real Estate e Heitman, assicurando 300 milioni di dollari per finanziare lo sviluppo di proprietà sanitarie progettate per scopi specifici. La fase iniziale comprende il finanziamento di sette progetti che totalizzano quasi 500.000 piedi quadrati in cinque stati, con inquilini come Ochsner Health e Andrews Medicine.
La joint venture mira a sviluppare edifici per ambulatori medici, centri ortopedici di eccellenza e strutture per riabilitazione per pazienti ricoverati. Questa partnership segna una pietra miliare significativa nella storia di oltre 20 anni di Heitman nel settore degli uffici medici, sfruttando le qualità contro-cicliche di questa classe di attivi basata sui bisogni.
Newmark Group, Inc. (Nasdaq: NMRK) ha organizado una colaboración estratégica entre Catalyst Healthcare Real Estate y Heitman, asegurando 300 millones de dólares para financiar el desarrollo de propiedades sanitarias específicas. La fase inicial incluye el financiamiento de siete desarrollos que totalizan casi 500.000 pies cuadrados en cinco estados, con inquilinos como Ochsner Health y Andrews Medicine.
La colaboración tiene como objetivo desarrollar edificios ambulatorios médicos, centros de excelencia ortopédica y instalaciones de rehabilitación para pacientes hospitalizados. Esta asociación marca un hito significativo en la historia de más de 20 años de Heitman en el sector de oficinas médicas, aprovechando las cualidades contracíclicas de esta clase de activos basada en necesidades.
뉴마크 그룹, Inc. (Nasdaq: NMRK)는 Catalyst Healthcare Real Estate와 Heitman 간의 전략적 합작 투자 계약을 체결하여 3억 달러를 확보하여 의료용 부동산 개발을 자금 지원합니다. 초기 단계에는 Ochsner Health 및 Andrews Medicine과 같은 세입자가 포함된 다섯 주에 걸쳐 총 500,000제곱피트에 달하는 7개의 개발 프로젝트에 대한 자금 지원이 포함됩니다.
이 합작 투자의 목표는 의료 외래 진료소, 정형외과 전문 센터 및 입원 치료 시설을 개발하는 것입니다. 이 파트너십은 Heitman이 20년 이상 의료 사무소 부문에 투자해 온 역사에서 중요한 이정표로, 수요 기반 자산 클래스의 역순환 특성을 활용하고 있습니다.
Newmark Group, Inc. (Nasdaq: NMRK) a organisé un partenariat stratégique entre Catalyst Healthcare Real Estate et Heitman, garantissant 300 millions de dollars pour financer le développement de propriétés de santé conçues à cet effet. La phase initiale comprend le financement de sept développements totalisant près de 500 000 pieds carrés dans cinq états, avec des locataires tels qu'Ochsner Health et Andrews Medicine.
Le partenariat vise à développer des bâtiments de soins ambulatoires médicaux, des centres d'excellence orthopédique et des installations de réhabilitation pour patients hospitalisés. Ce partenariat marque une étape importante dans l'histoire de plus de 20 ans de Heitman dans le secteur des bureaux médicaux, tirant parti des qualités contre-cycliques de cette classe d'actifs basée sur les besoins.
Die Newmark Group, Inc. (Nasdaq: NMRK) hat ein strategisches Joint Venture zwischen Catalyst Healthcare Real Estate und Heitman arrangiert und 300 Millionen US-Dollar zur Finanzierung der Entwicklung von speziell errichteten Gesundheitsimmobilien gesichert. Die erste Phase umfasst die Finanzierung von insgesamt sieben Entwicklungen mit fast 500.000 Quadratfuß in fünf Bundesstaaten mit Mietern wie Ochsner Health und Andrews Medicine.
Das Joint Venture zielt darauf ab, medizinische ambulante Gebäude, orthopädische Exzellenzzentren und stationäre Rehabilitationseinrichtungen zu entwickeln. Diese Partnerschaft markiert einen bedeutenden Meilenstein in der über 20-jährigen Geschichte von Heitman im Bereich der medizinischen Büros und nutzt die antizyklischen Eigenschaften dieser bedarfsorientierten Anlageklasse.
- Secured $300 million funding for healthcare property development
- Initial phase includes 7 developments totaling nearly 500,000 square feet
- Partnership with blue chip tenants like Ochsner Health and Andrews Medicine
- Expansion into a counter-cyclical, needs-based asset class
- None.
The $300 million joint venture between Catalyst Healthcare Real Estate and Heitman, arranged by Newmark, is a significant development in the healthcare real estate sector. This partnership combines Catalyst's expertise in healthcare real estate development with Heitman's substantial
The venture's focus on purpose-built healthcare properties, including medical outpatient buildings and rehabilitation facilities, aligns with the ongoing trend of healthcare services shifting from hospitals to outpatient settings. This strategy could potentially yield stable, long-term returns due to the essential nature of healthcare services and the aging population demographic.
The initial phase, funding seven developments across five states with nearly 500,000 square feet of space, demonstrates a robust pipeline. The involvement of blue-chip tenants like Ochsner Health and Andrews Medicine suggests strong potential for reliable cash flows, which is important for real estate investment success.
This joint venture signifies a strategic shift in healthcare real estate, reflecting the industry's move towards more specialized, outpatient-focused facilities. The development of orthopedic centers of excellence and inpatient rehabilitation facilities aligns with the trend of value-based care, emphasizing specialized treatment centers for improved patient outcomes and cost efficiency.
The partnership's focus on purpose-built healthcare properties could potentially enhance healthcare delivery by creating tailored environments for specific medical services. This approach may lead to improved patient experiences and potentially better health outcomes, which could make these properties attractive to healthcare providers looking to optimize their real estate strategies.
The involvement of major health systems as tenants suggests a long-term commitment to these facilities, which could provide stability for the venture and potentially lead to future expansion opportunities in the healthcare real estate market.
The formation of this joint venture highlights the growing attractiveness of healthcare real estate as an investment class. The sector's counter-cyclical qualities, driven by needs-based demand and demographic trends, make it a compelling option for diversification in real estate portfolios.
The $300 million commitment demonstrates significant confidence in the healthcare real estate market. This substantial investment could potentially lead to increased competition for prime healthcare properties and drive further innovation in the sector.
The venture's focus on multiple states suggests a strategy of geographic diversification, which could help mitigate regional economic risks. Additionally, the mix of ground-up and in-process developments indicates a balanced approach to risk and return, potentially providing both near-term cash flow from existing projects and long-term value creation from new developments.
The transaction was led by Newmark's Healthcare Capital Markets group Executive Managing Director Ben Appel, Senior Managing Director John Nero, Executive Managing Director Jay Miele, Senior Managing Director Michael
The initial phase includes funding seven ground-up or in-process developments totaling nearly 500,000 square feet, spanning five states and encompassing blue chip tenants such as Ochsner Health, Andrews Medicine, University of Mississippi Medical Center and PAM Health.
"Catalyst works in partnership with its clients to design comprehensive real estate solutions that best support their mission, vision and values of providing better access to care, higher quality outcomes and lasting relationships," said Chad Henderson, Founder/CEO and Managing Partner of Catalyst Healthcare Real Estate.
"The joint venture with Catalyst is another significant milestone in Heitman's 20+ year history of investing in the medical office sector," said Brian Pieracci, Heitman Head of Private Equity –
"Catalyst prides itself on its people, its promise and the quality of its work," added Appel. "The firm has been recognized nationally for both its people, including CEO Chad Henderson, and for the quality of its developments."
"Supporting the growth of many of the nation's leading providers, the Venture further solidifies Catalyst's business plan to execute its ambulatory strategy," added Nero.
About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries ("Newmark"), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark's comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform's global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the year ended December 31, 2023, Newmark generated revenues of approximately
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company's business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.
About Catalyst Healthcare Real Estate
Catalyst is a national healthcare real estate development and investment firm. Our platform of integrated real estate deliverables is specifically designed for the ever-evolving landscape of healthcare real estate. Our team seeks to positively impact healthcare with strategic investment in development, acquisition, and strategy services. For more information, please visit catalysthre.com.
About Heitman
Heitman is a global real estate investment management firm with
View original content to download multimedia:https://www.prnewswire.com/news-releases/newmark-arranges-300m-joint-venture-between-catalyst-and-heitman-302218175.html
SOURCE Newmark Group, Inc.
FAQ
What is the value of the joint venture arranged by Newmark (NMRK) for Catalyst and Heitman?
How many developments are included in the initial phase of the Catalyst-Heitman joint venture?
What types of healthcare properties will be developed through the Newmark-arranged joint venture?
Who are some of the tenants for the properties in the Catalyst-Heitman joint venture?
